⌘K

Login Start Free

Home/Filings/4/A/0001127602-24-016231

4/A//SEC Filing

De Witte Jan 4/A

Accession 0001127602-24-016231

CIK 0000943819other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 2:51 PM ET

Size

4.5 KB

Accession

0001127602-24-016231

Insider Transaction Report

Form 4/AAmended

Period: 2024-05-15

Director

Transactions

Sale
ReMed Common Stock
2024-05-15$218.29/sh−360$78,584→ 7,519 total

Footnotes (1)

[F1]Amended to indicate that the transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001776929

Filing Metadata

Form type: 4/A
Filed: May 21, 8:00 PM ET
Accepted: May 22, 2:51 PM ET
Size: 4.5 KB

View on SEC.gov